Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals, Inc. financial statements

Elite Pharmaceuticals, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2026

RevenueUSD 148.87M10-K
Net incomeUSD 44.87M10-K
Cash and equivalentsUSD 29.8M10-Q

Elite Pharmaceuticals, Inc. financials on 6ix · Elite Pharmaceuticals, Inc. on 6ix